Read an interesting article on Ranbaxy's sale to Daichii and the probable reason behind the sale.
http://knowledge.wharton.upenn.edu/india/article.cfm?articleid=4296
Interesting thing is the hint that probably india has hit a fundamental problem in the pharma : NO innovation.
Have a look at the above warton news letter. It is a balanced look at the deal and pharma in general
No comments:
Post a Comment